Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris

Journal of Dermatology

Volumn 26, Issue 11, 1999, Pages 748-752

  Hertl, Michael ^a   Riechers, Regine ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

Autoreactive T helper cells; Cytokines; Desmoglein 3; Epitopes; HLA class II alleles

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; DESMOGLEIN; EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 4;

ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; PEMPHIGUS VULGARIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033399896     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02086.x     Document Type: Article

References (24)

1. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR: Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic, J Clin Invest, 90: 919-924, 1992.
2. Amagai M, Hashimoto T, Shimizu N, Nishikawa T: Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus, J Clin Invest, 94: 59-67, 1994.
3. Bhol K, Ahmed AR, Aoki V, Mohimen A, Nagarwalla N, Natarajan K: Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: A model for autoimmunity, Proc Natl Acad Sci USA, 92: 5239-5243, 1995.
4. Hashimoto T, Amagai M, Watanabe K, et al: A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins, J Invest Dermatol, 104: 541-544, 1995.
5. Bedane C, Prost C, Thomine E, et al: Binding of autoantibodies is not restricted to desmosomes in pemphigus vulgaris: Comparison of 14 cases of pemphigus vulgaris and 10 cases of pemphigus foliaceus studied by Western immunoblot and Immunoelectron microscopy, Arch Dermatol Res, 288: 343-352, 1996.
6. Huilgol SC, Black MM: Management of the immunobullous disorders. II. Pemphigus, Clin Exp Dermatol, 20: 283-293, 1995.
7. Kumar V, Kono VD, Urban JL, Hood L: The T cell receptor repertoire and autoimmune diseases, Annu Rev Immunol, 7: 657-682, 1989.
8. Ahmed AR, Yunis EJ, Khatri K, et al: Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris, Proc Natl Acad Sci USA, 87: 7658-7662, 1990.
9. Ahmed AR, Wagner R, Khatric K, et al: Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris, Proc Natl Acad Sci USA, 88: 5056-5061, 1991.
10. Szafer F, Brautbar C, Tzfoni E, et al: Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region, Proc Natl Acad Sci USA, 84: 6542-6548, 1987.
11. Sinha AA, Brautbar C, Szafer F, et al: A newly characterized HLA-DQβ allele associated with pemphigus vulgaris, Science, 239: 1026-1029, 1988.
12. Ahmed AR, Mohimen A, Yunis AJ, et al: Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients, J Exp Med, 177: 419-424, 1993.
13. Wucherpfennig KW, Yu WB, Bhol K, et al: Structural basis for major histocompatibility complex (MHC) -linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris, Proc Natl Acad Sci USA, 92: 11935-11939, 1995.
14. Lin MS, Swartz SJ, Lopez A, et al: Development and characterization of desmoglein 3-specific T cells from patients with pemphigus vulgaris, J Clin Invest, 99: 31-40, 1997.
15. Hertl M, Amagai M, Sundaram H, Stanley JR, Ishii K, Katz SI: Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals, J Invest Dermatol, 110: 62-66, 1998.
16. Hertl M, Karr RW, Amagai M, Katz SI: Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3-specific T cell responses in pemphigus vulgaris patients and normals, J Invest Dermatol, 110: 388-392, 1998.
17. Riechers R, Grötzinger J, Hertl M: HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris. Review of the literature and potential applications for the development of a specific immunotherapy, Autoimmunity, (in press)
18. Fredrikson S, Sun JB, Huang WH, Li BL, Olsson T, Link H: Cord blood contains high number of autoimmune T cells recognizing multiple myelin proteins and acetylcholine receptor, J Immunol, 151: 2217-2224, 1993.
19. Martin R, Voskuhl R, Flerlage M, McFarlin DE, McFarland H: Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis, Ann Neurol, 34: 524-535, 1993.
20. Hammer J, Gallazzi F, Bono CP, et al: Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association, J Exp Med, 181: 1847-1855, 1995.
21. Kwok WW, Nepom GT, Raymond FC: HLA-DQ polymorphisms are highly selective for peptide binding interactions, J Immunol, 155: 2468-2476, 1995.
22. Valmori D, Sabbatini A, Lanzavecchia A, Corradin G, Matricardi PM: Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles, J Immunol, 152: 2921-2927, 1993.
23. Büdinger L, Borradori L, Yee C, et al: Identification and characterization of autoreactive T cell responses to bullous pemphigoid (BP) antigen 2 in patients with BP and healthy controls, J Clin Invent, 102: 2082-2089, 1998.
24. Gascan H, Gauchat JF, Roncarolo MG, Yssel H, Spits H, de Vries JE: Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones, J Exp Med, 173: 747-750, 1992.